Company Financials

Axsome Therapeutics, Inc. Financials

United States dollar

business Axsome Therapeutics, Inc. Company Profile

Main Stock Listing

NASDAQ: AXSM

Market Capitalization $9.01 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -29.83
Forward PE 593.93
Price to Sales TTM $16.05
Price to Book MRQ $121.89
Enterprise to Revenue 15.86
Enterprise to EBITDA -47.36

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -40.89%
Operating Margin -19.25%
Return on Assets TTM -19.79%
Return on Equity TTM -275.50%

Income Statement

Revenue TTM $561,262,976
Revenue per Share TTM $11.40
Quarterly Revenue Growth 63.20%
Gross Profit TTM $515,600,000
EBITDA $-187,948,992
Net Income to Common TTM $-229,527,008
Diluted EPS TTM $-4.66
Quarterly Earnings Growth YoY 63.22%

Balance Sheet

Total Cash MRQ $325,272,000
Total Cash per Share MRQ $6.45
Total Debt MRQ $
Total Debt to Equity MRQ 296.49
Current Ratio MRQ 1.57
Book Value per Share MRQ $1.47

Cash Flow

Operating Cash Flow TTM $-100,954,000
Levered Free Cash Flow TTM $-17,762,124

AXSM Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 50,307,834
Float Shares 42,498,360
Avg 10 Volume 809,667
Avg 30 Volume None
Shares Short 2,835,683
Short Ratio 5.36
Short % of Shares 6.69%
% Held by Insiders 15.70%
% Held by Institutions 76.63%

Stock Price Summary

Beta 0.47
Fifty Two Week Low $79.19
Fifty Two Week High $184.40
Fifty Two Week Change 52.36%
Day 50 MA $144.32
Day 200 MA $119.69

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date